Hematopoietic Stem Cell Transplantation in Children with Autoimmune Connective Tissue Diseases

被引：0
作者：
Magdalena Witkowska
Elzbieta Smolewska
Piotr Smolewski
机构：
[1] Medical University of Lodz,Department of Experimental Hematology
[2] Medical University of Lodz,Department of Pediatric Cardiology and Rheumatology
来源：
Archivum Immunologiae et Therapiae Experimentalis | 2014年 / 62卷
关键词：
Autoimmune connective tissue diseases; Children; Treatment; Hematopoietic stem cell transplantation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Autoimmune connective tissue diseases (ACTDs) are heterogeneous disorders associated with different manifestations, clinical course of disease and prognosis among patients. Although recent advances in understanding the pathogenesis have led to major progress in target-oriented therapy, they still remain incurable. Novel biological drugs, cellular therapy and hematopoietic stem cell transplantation (HSCT) are real hopes for treatment development in the future. The concept of both autologous and allogeneic HSCT in children with autoimmune diseases is developing energetically since 1996, when the first HSCT was performed. Nowadays, after 17 years of clinical experience, both types of HSCT remain attractive and powerful salvage methods of treatment. However, there are still many doubts and unclear issues, which need further investigation. In the present review, we provide an overview of the knowledge concerning actual data on HSCT in a pediatric group of patients with different ACTDs, focused on juvenile idiopathic arthritis, systemic lupus erythematosus and systemic sclerosis.
引用
收藏
页码：319 / 327
页数：8
相关论文
共 152 条
[1]  
Adib N(2005)Outcome following onset of juvenile idiopathic inflammatory arthritis: II. Predictors of outcome in juvenile arthritis Rheumatology 44 1002-1007
[2]  
Silman A(2001)Haematopoietic cell transplantation as immunotherapy Nature 411 385-389
[3]  
Thomson W(2012)Scleroderma—new aspects in pathogenesis and treatment Best Pract Res Clin Rheumatol 26 13-24
[4]  
Appelbaum FR(1977)Bone marrow transplantation in patients with gold-induced marrow aplasia Arthr Rheum 20 1043-1048
[5]  
Balbir-Gurman A(1997)Celiac disease transmitted by allogeneic non-T cell-depleted bone marrow transplantation Bone Marrow Transpl 20 607-609
[6]  
Braun-Moscovici Y(2001)The immune dysregulation, polyendocrinopathy, enteropathy, X linked syndrome (IPEX) is caused by mutations FOXP3 Nat Genet 27 20-21
[7]  
Baldwin JL(1999)Adoptive autoimmune hyperthyroidism following allogeneic stem cell transplantation from an HLA-identical sibling with Graves’ disease Bone Marrow Transpl 23 1091-1092
[8]  
Storb R(2012)Novel biological treatments for systemic lupus erythematosus: current and future modalities Isr Med Assoc J 14 508-514
[9]  
Thomas ED(2007)Autologous stem cell transplantation in children with severe progressive systemic or polyarticular juvenile idiopathic arthritis: long-term follow-up of a prospective clinical trial Arthr Rheum 56 2410-2421
[10]  
Bargetzi MJ(2005)Use of CD Clin Rheumatol 24 464-468
12345678910